Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Non-Current Deffered Revenue (2021)

Medicinova (MNOV) has disclosed Non-Current Deffered Revenue for 3 consecutive years, with $1.7 million as the latest value for Q2 2021.

  • On a quarterly basis, Non-Current Deffered Revenue changed N/A to $1.7 million in Q2 2021 year-over-year; TTM through Jun 2021 was $1.7 million, a N/A change, with the full-year FY2013 number at $1.7 million, changed N/A from a year prior.
  • Non-Current Deffered Revenue was $1.7 million for Q2 2021 at Medicinova, roughly flat from $1.7 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $1.7 million in Q1 2021 to a low of $1.7 million in Q1 2021.